How clinical labs can confidently assess cancer-associated variants with real-world data and expert-curated genomic evidence

December 07, 2023
Across various stages of the clinical oncology workflow, from panel design to genomic testing and molecular tumor boards, the identification and validation of actionable genomic alterations is critical. The advent of next-generation sequencing (NGS) has led to an exponential increase in the number of variants detected in tumor testing, posing a challenge for clinical cancer genetics professionals seeking to confidently discern clinically relevant mutations that can guide patient care decisions.

Join Dr. Umadevi Thirumurthi, Associate Director of Global Product Management for Oncology at QIAGEN Digital Insights as she discusses how the Human Somatic Mutation Database (HSMD), an expert-curated somatic variant database, can enhance your clinical NGS workflow.

Related videos


Somatic variants investigation in critical regulatory pathways

213 views August 25, 2022

This training will focus on using QIAGEN Ingenuity Pathway analysis (IPA) and...

Gene Variant Databases

Identify meaningful mutations in somatic tumor testing

1,154 views February 14, 2022

From Information Overload to Actionable Insights Precision medicine is...

Gene Variant Databases

Access to real-world data and 2 decades of expert curation

2,680 views October 01, 2021

Across oncology applications, from research to molecular testing and...